AA
Affinity Asset Advisors, LLC disclosed a 10% stake in NXTC
Affinity Asset Advisors, LLC reported owning 10% of NextCure, Inc. (NXTC) (475,626 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More NXTC insider and Congress trades
- BuyNXTC · ADAR1 Capital Management, LLC$63KNov 13, 2026
- BuyNXTC · ADAR1 Capital Management, LLC$24KNov 9, 2026
- BuyNXTC · ADAR1 Capital Management, LLC$54KOct 27, 2026
- SellNXTC · Simcere Zaiming, Inc.$185KAug 12, 2026
- BuyNXTC · ADAR1 Capital Management, LLC$1.6MAug 3, 2026
- BuyNXTC · ADAR1 Capital Management, LLC$88KJul 29, 2026